Compare Motorola Solutions Inc (MSI) vs Pfizer Inc (PFE) Price & Performance

Motorola Solutions (MSI) trades at $462.98, down 1.08% on the day, amid a bullish technical setup with strong support at $459. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $4.41 surpassing the $3.85 estimate. Revenue growth is steady, reaching $11.68 billion in 2025, while net income margin improved to 17.44%. Recent news highlights a $2 billion share repurchase authorization and the completion of the $1.5 billion D-Fend Solutions acquisition, expanding its counter-drone portfolio.

The outlook remains positive given analyst consensus favoring Buy ratings (70.59%) and a price target of $536.50, implying ~16% upside. Key risks include elevated valuation multiples (P/E 36.48) and significant investing cash outflows ($-5.16 billion in 2025) from acquisitions. Execution on integration and debt management will be critical for sustaining shareholder value amid competitive pressures.

Pfizer (PFE) trades at $27.78, down 2.36% today, with a consensus price target of $28.33 suggesting modest upside. The stock shows mixed technical signals with bullish moving averages but neutral oscillators. Recent earnings have consistently beaten expectations, though revenue declined from pandemic peaks. The company maintains strong cash flow generation and a solid dividend yield of approximately 3.1%.

Pfizer presents a value opportunity with reasonable valuation metrics and dividend stability, but faces headwinds from post-COVID revenue normalization and patent expirations. The company's pipeline progress in obesity and oncology could drive future growth, though execution risks remain. Analyst sentiment leans cautious with 59% hold ratings.